These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16786130)

  • 1. Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.
    Andoh A; Deguchi Y; Inatomi O; Yagi Y; Bamba S; Tsujikawa T; Fujiyama Y
    Oncol Rep; 2006 Jul; 16(1):103-7. PubMed ID: 16786130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function.
    Irani AM; Craig SS; DeBlois G; Elson CO; Schechter NM; Schwartz LB
    J Immunol; 1987 Jun; 138(12):4381-6. PubMed ID: 3295046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L; Kuiper I; van Duijn W; Marklund SL; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):7-16. PubMed ID: 12950012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
    Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
    J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
    Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
    Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease.
    Vizoso FJ; González LO; Corte MD; Corte MG; Bongera M; Martínez A; Martín A; Andicoechea A; Gava RR
    Scand J Gastroenterol; 2006 Sep; 41(9):1050-5. PubMed ID: 16938718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
    Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
    J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopsy histamine in ulcerative colitis and Crohn's disease.
    Baenkler HW; Lux G; Günthner R; Kohlhäufl M; Matek W
    Hepatogastroenterology; 1987 Dec; 34(6):289-90. PubMed ID: 3428863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
    Howard PS; Renfrow D; Schechter NM; Kucich U
    Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of novel tissue microarrays to investigate expression of tryptase, chymase and KIT protein in placental mast cells.
    Noack F; Krüger S; Thorns C; Finas D; Stöcker W; Diedrich K; Horny HP
    Arch Gynecol Obstet; 2005 Sep; 272(3):223-8. PubMed ID: 16142475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical characterization, distribution and quantification of different mast cell subtypes in transmural biopsies from the gastrointestinal tract of cats with inflammatory bowel disease.
    Kleinschmidt S; Harder J; Nolte I; Marsilio S; Hewicker-Trautwein M
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):190-200. PubMed ID: 20646765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
    Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
    Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis.
    Badertscher K; Brönnimann M; Karlen S; Braathen LR; Yawalkar N
    Arch Dermatol Res; 2005 Apr; 296(10):503-6. PubMed ID: 15703960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
    Mazumdar S; Das KM
    Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
    ter Beek WP; Muller ES; Van Hogezand RA; Biemond I; Lamers CB
    J Clin Pathol; 2004 Oct; 57(10):1047-51. PubMed ID: 15452158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.